Orchid Logo
Embryo Report
PGT-MPGT-SR
Log inContact Us
Orchid Logo

Embryo Report

Advanced genetic screen for your embryos. Prevent your child from inheriting a predisposition to a condition that runs in your family.

VIEW DETAILSGET ACCESS

Couple Report

Our preconception test measures your future child's genetic predisposition to disease. Mitigate your risk.

For Patients

OverviewRisk CalculatorGuidesBook a Call

For Clinicians

Log inContact Us

Careers

Our mission is to extend the healthspan of the next generation

Today, over 100 million Americans suffer from at least one chronic disease. With no cure, our friends and families are leashed to treatments that address symptoms rather than root causes.

Our aim is to slash incidence rates of disease in the next generation. We detect risk at the earliest stages, and give couples the ability to tilt the odds toward extending their children's healthspan - the number of years of life uninterrupted by disease.

What we do

Working to give everyone the ability to have a healthy child

Orchid is a reproductive technology company working to give everyone the ability to have a healthy child. We are doing the difficult work of measuring and mitigating genetic risk—so the next generation can concentrate on life, not managing a disease.

We're building ultra high resolution genetic reports so that, for the first time in human history, prospective parents can protect their future children from inheriting a predisposition to the most common diseases -- not just rare ones.

Life is short, do work that matters.

All roles are remote-friendly. We are based in San Francisco.

What we offer

  • The opportunity to have a trajectory-altering impact on humanity
  • The opportunity to grow rapidly and influence engineering, product, and the strategic direction of the company
  • Competitive compensation (base, equity, generous benefits)

Open Positions

Join our team

Life at Orchid

We're a low-ego team of optimistic builders who care deeply about helping every couple have a healthy baby, and we're looking for exceptional individuals to join the team.

Add to humanity's capabilities

At Orchid, we're working on bringing a new capability for humanity online - the ability to measure and mitigate genetic risk for the diseases that matter most. Instead of health being a genetic lottery at birth, we want every prospective parent to have the information and choice to protect their child from inheriting health risks.

Do the most significant work of your career

Having a child is a big step in life. Your work directly contributes to a life altering moment for prospective parents and has the potential to bend the trajectory of a child's life toward a healthier future.

Why Now?

A defining moment in genomic medicine

Genomic datasets are exploding in size

In 1990, we started without the ability to even read the 3.2 billion letters in the human genome. We spent 13 years and $3 billion dollars assembling the very first sequence. Since then, the cost of sequencing has plummeted, enabling millions of human genomes to be assembled, often paired with physician-verified diagnoses. The goal of genomic medicine is on the cusp of realization - we have a newfound ability to measure genetic susceptibility for the most common diseases.

Define a new category

Historically, we haven't been able to move beyond rolling the dice to determine health outcomes in the next generation. Be a part of defining a fundamentally new category of precision medicine. Today, we have the opportunity to give parents high resolution data to stack the odds in their child's favor - against diseases that have burdened families for generations.

The Team

Orchid is led by world-class experts

The technology behind Orchid has been developed by experts in statistical genetics, computational biology, and fertility committed to helping families understand and mitigate their reproductive risks.

Jacques Cohen, PhD

Jacques Cohen, PhD

Pioneering Embryologist and foundational figure in IVF and ART innovation

Roohi Jeelani, MD

Roohi Jeelani, MD

Double board certified Reproductive Endocrinologist and Infertility Specialist (REI)

Lusine Aghajanova, MD, PhD

Lusine Aghajanova, MD, PhD

Clinical Assistant Professor at the Stanford Medical Center

Barry Behr, PhD

Barry Behr, PhD

Professor of Obstetrics and Gynecology Emeritus at the Stanford Medical Center

Jan Liphardt, PhD

Jan Liphardt, PhD

Professor of Bioengineering at Stanford University

Nathan Slotnick, MD, PhD

Nathan Slotnick, MD, PhD

Perinatologist and Medical Geneticist

Amber Cooper, MD

Amber Cooper, MD

Double board certified Obstetrics and Gynecologist and Reproductive Endocrinologist and Infertility Specialist

Investors

Backed by the top founders in technology and health

Orchid is backed by the top founders in technology and health - including the founders of Coinbase, Counsyl, 23andMe, Flatiron, Eventbrite, Oscar, and Clover - as well as Refactor Capital, Day One Ventures, and Village Global.

George Church

George Church

Professor of Genetics at Harvard Medical School and MIT

Elad Gil

Elad Gil

Entrepreneur and Investor, Co-Founder of Color Genomics

Vitalik Buterin

Vitalik Buterin

Co-Founder of Ethereum

Anne Wojcicki

Anne Wojcicki

Co-Founder & CEO, 23andMe

Carlos Bustamante

Carlos Bustamante

MacArthur Award Winning Geneticist

Brian Armstrong

Brian Armstrong

CEO of Coinbase, Co-Founder of NewLimit

Have healthy babies.

PRODUCTS

Embryo ReportCouple Report

FOR PATIENTS

OverviewRisk CalculatorGuidesBook a Call

FOR CLINICIANS

OverviewScience

© 2025 Orchid

Orchid
GET STARTED